The effects of anti-rheumatic drugs (lobenzarit (CCA) ; 10 and 50mg/kg, cyclophosphamide (CP) ; 5mg/kg and dexamethasone (DM) ; 0.25mg/kg) were evaluated immunologically and histopathologically on DBA/1J mice that develop polyarthritis after immunization by the intradermal injection of type II collagen. Serum anti-type II collagen IgG levels in the groups treated with CP and DM were significantly suppressed to 1/2 and 1/10 as compared to those of the positive control group, respectively. Those of both groups treated with CCA were not different from those of the positive control group. Histopathological examination revealed that treatment with CP and DM markedly reduced or suppressed inflammatory changes and resulted in low incidence of arthritis. From the standpoint mentioned above, treatment with anti-rhematic drugs suppressed the development of arthritis in this model, and we could confirmthat this model was useful for evaluation of the effect of anti-rheumatic drugs.DBA/ 1 J mouse is known to develop polyarthritis after immunization by the injection of type II collagen [2,3,6,14], and recently it arouses general interest as an experimental model of human rheumatoid arthritis. Previous histological examination revealed that the sequence of arthritic lesions was not uniform by each joint [41. Evaluation of the effects of anti-rheumatic drugs had been conducted in this model using macroscopic or immunologic criteria by Phadke et al. [10], Paska et al. [9] and etc.In the present study as the second series of experiments dealing with type II collagen induced polyarthritis in DBA/1J mouse, anti-rheumatic drugs of different categories were administered to the model animals and the limb joints were examined histopathologically to investigate the feasibility of this model for the evaluation of anti-rhematic agents.